Assessment of outcome in depression

Journal of Psychopharmacology

Volumn 20, Issue 4 SUPPL., 2006, Pages 47-53

  Nelson, J Craig ^a   Portera, Laura ^b   Leon, Andrew C ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Munroe Township   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Antidepressant response; Assessment; Core symptoms; Major depression; Rating scales

Indexed keywords

FLUOXETINE; REBOXETINE;

CLINICAL TRIAL; DEPRESSION; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; GYNECOLOGIC DISEASE; HAMILTON SCALE; HUMAN; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; REVIEW; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VALIDATION PROCESS;

ADRENERGIC UPTAKE INHIBITORS; ANTIDEPRESSIVE AGENTS; DEPRESSION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SEROTONIN UPTAKE INHIBITORS;

EID: 33750080476     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/1359786806066046     Document Type: Review

References (34)

1. Andreoli V, Caillard V, Deo R S, Rybakowski J K (2002) Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression. J Clin Psychopharmacology 22: 393-399
2. Bagby R M, Ryder A G, Schuller D R, Marshall M B (2004) The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 161: 2163-2177
3. Bech P, Gram L F, Dein E, Jacobsen O, Vitger J, Bolwig T G (1975) Quantitative rating of depressive states. Acta Psychiatrica Scandinavica 51: 161-170
4. Beck A T, Steer R A, Garbing M G (1988) Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev 8: 77-100
5. Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Erlbaum, Hillsdale, NJ
6. Edwards B C, Lambert M J, Moran P W, McCully T, Smith K C, Ellingson A G (1984) A meta-analytic comparison of the Beck Depression Inventory and Hamilton Rating Scale for Depression as measures of treatment outcome. Br J Clin Psychol 23 (part 2): 93-99
7. Endicott J, Nee J, Harrison W, Blumenthal R (1993) Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 29: 321-326
8. Evans K R, Sills T, DeBrota D J, Gelwicks S, Engelhardt N, Santor D (2004) An item response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies. J Psychiat Res 38: 275-284
9. Faries D, Herrera J, Rayamajhi J, DeBrota D, Demitrack M, Potter W Z (2000) The responsiveness of the Hamilton Depression Rating Scale. J Psychiatric Res 34: 3-10
10. First M B, Spitzer R L, Gibbon M (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York State Psychiatric Institute, Biometrics Research, November
11. Gibbons R D, Clark D, Kupfer D J (1993) Exactly what does the Hamilton Depression Rating Scale measure? J Psychiat Res 27: 259-273
12. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62
13. Healy D, McMonagle T (1997) The enhancement of social functioning as a therapeutic principle in the management of depression. J Psychopharmacol 11 (suppl. 4): S25-31
14. Lambert M J, Hatch D R, Kingston M D, Edwards B C (1986) Zung, Beck, and Hamilton Rating Scales as measures of treatment outcome: a meta-analytic comparison. J Consult Clin Psychol 54: 54-59
15. Landin R, DeBrota D J, DeVries T A, Potter W Z, Demitrack M A (2000) The impact of restrictive entry criterion during the placebo lead-in period. Biometrics 56: 271-278
16. Leon A C (2004) Are two antidepressant mechanisms better than one? Issues in clinical trial design and analysis. J Clinical Psychiatry 65 (suppl. 4): 31-36
17. Leon A C, Shear M K, Portera L, Klerman G L (1993) Effect size as a measure of symptom-specific change in clinical trials. Psychopharmacol Bull 29: 163-167
18. Maier W, Philipp M (1985) Improving the assessment of severity of depressive states: a reduction of the Hamilton Depression Scale. Pharmacopsychiat 18: 114-115
19. Massana J, Moller H-J, Burrows G D, Montenegro R M (1999) Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder. Int Clin Psychopharmacol 14: 73-80
20. Mazure C, Nelson J C, Price L H (1986) Reliability and validity of the symptoms of major depressive illness. Arch Gen Psychiatry 43: 451-456
21. Montgomery S A, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiat 134: 382-389
22. Nelson J C, Mazure C M, Quinlan D M, Jatlow P I (1984) Drug-responsive symptoms in melancholia. Arch Gen Psychiatry 41: 663-668
23. Nelson J C, Portera L, Leon A C (2005a) Are there differences in the symptoms that respond to a selective serotonin or norepinephrine reuptake inhibitor? Biol Psychiatry 57: 1535-1542
24. Nelson J C, Portera L, Leon A C (2005b) Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine. J Clin Psychiatry 66: 1409-1414
25. Nelson J C, Clary C M, Leon A C, Schneider L S (2005c) Symptoms of late life depression: frequency and change during treatment. Am J Geriatr Psychiatry 13: 520-526
26. Radloff L S (1977) The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1: 385-401
27. Rush A J, Bernstein I H, Trivedi M H, Carmody T J, Wisniewski S, Mundt J C, Shores-Wilson K, Biggs M M, Woo A, Nierenberg A A, Fava M (2006) An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry 59: 493-501
28. Rush A J, Giles D E, Schlesser M A, Fulton C L, Weissenburger J, Burns C T (1986) The inventory of depressive symptomatology (IDS): preliminary findings. Psychiatry Res 18: 65-87
29. Rush A J, Trivedi M H, Ibrahim H M, Carmody T J, Arnow B, Klein D N, Markowitz J C, Ninan P T, Kornstein S, Manber R, Thase M E, Kocsis J H, Keller M B (2003) The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), Clinician Rating (QIDS-C) and Self-Report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 54: 573-583
30. Santor D A, Coyne J C (2001) Examining symptom expression as a function of symptom severity: item performance on the Hamilton Rating Scale for Depression. Psychological Assessment 13: 127-139
31. Sheehan D V, Lecrubier Y, Sheehan K H (1998) The Mini-International Neuropsychiatrie Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (suppl 20): 22-33
32. Stahl S M (2000) In: Essential Psychopharmacology, 2nd edn. Cambridge University Press, New York, NY, pp. 135-197, 222-295
33. Ware J E Jr, Sherbourne C D (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473-483
34. Zimmerman M, Posternak M, Friedman M, Attiullah N, Baymiller S, Boland R, Berlowitz S, Rahman S, Uy K, Singer S (2004) Which factors influence psychiatrists' selection of antidepressants? Am J Psychiatry 161: 1285-1289